Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, the DSP Cancer Institute, and the Oncology Clinical Development Unit, will collectively be known as Sumitomo Pharma Oncology. SP Oncology brings together a team of highly engaged oncology expe...
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, the DSP Cancer Institute, and the Oncology Clinical Development Unit, will collectively be known as Sumitomo Pharma Oncology. SP Oncology brings together a team of highly engaged oncology experts who leverage their passion for challenging work to collaborate across geographies and realize a common goal—advancing purposeful science by transforming new discoveries.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.